MENU
PROK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ProKidney (PROK) Ownership - Who owns ProKidney?

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes... Show more

Profile

Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7019
Employees
231
Web
https://www.prokidney.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
359.1M
P/E Ratio
N/A
Total Cash
224.94M
Projected Growth
N/A
Total Debt
3.78M
Revenue
889K
Risk (Beta)
2.98
Dividend Yield
N/A
Total Cash/Share
1.10
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
View a ticker or compare two or three
PROK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7019
Employees
231
Web
https://www.prokidney.com